by emilyboland | Dec 6, 2020 | News, Uncategorised
Medtech company Control Bionics (ASX:CBL) will list on the ASX next week. The company’s EMG (electromyography)-based technology helps people with disabilities inhibiting communications to do so through electronic devices that pick up their neuroelectric systems....
by emilyboland | Sep 1, 2020 | News
Control Bionics Launches World-Class Multi-Modal Augmentative and Alternative Communications (AAC) Device for Those with Speech and Motor Disorders With Unique Combination of Technologies, New GridPad Trilogy™ Delivers Faster Communication Speed and Less User Fatigue...
by emilyboland | Jun 4, 2020 | News
To Our Clients, Caregivers, and Clinicians: As we’ve globally transitioned into telepresence communication, we will still be offering our remote assessments alongside our industry-leading customer support. We understand that some communication needs, and...
by emilyboland | Mar 17, 2020 | News
Your NeuroNode Trilogy should be cleaned and disinfected on a regular basis. We recommend Super Sani-Cloth Germicidal Disposable Wipes for this. While Control Bionics routinely follows these procedures internally, we understand in light of the Covid-19 virus that...
by emilyboland | Jan 24, 2020 | News
Control Bionics was founded by Peter Shann Ford in 2006 to address the most difficult cases of loss of speech and mobility. Ford and the Control Bionics team have added much to the original work, particularly in the miniaturization of the equipment, in the improvement...
by emilyboland | Feb 6, 2019 | News
The NeuroNode Trilogy provides three access methods in a single funding accessible solution for degenerative conditions. MILFORD, OH – Feb.5, 2019 – Control Bionics Launches a new AAC package, the NeuroNode Trilogy, that significantly reduces user fatigue...
